Do you want to read an article? Please log in or register.
Differentiating Enhancing Multiple Sclerosis Lesions, Glioblastoma, and Lymphoma with Dynamic Texture Parameters Analysis (DTPA) - a Feasibility Study
Multiple Sclerosis
Related content
Multiple Sclerosis
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions
Mult Scler.
Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R
doi: 10.1177/1352458519885106.
Multiple Sclerosis
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
Ther Adv Neurol Disord.
Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S
doi: 10.1177/
RECOMMENDED
Multiple Sclerosis
PARAMAGNETIC RIM LESIONS ARE SPECIFIC TO MULTIPLE SCLEROSIS: AN INTERNATIONAL MULTICENTER 3T MRI STUDY
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Ann Neurol.
Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, Nath A, Ohayon J, van Pesch V, Perrotta G, Pot C, Théaudin M, Martinelli V, Scotti R, Wu T, Du Pasquier R, Calabresi PA, Filippi M, Reich DS, Absinta M
doi: 10.1002/ana.25877.
Aging and Cognitive FunctionsMultiple Sclerosis
Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset
Brain Topogr.
Altermatt A, Gaetano L, Magon S, Häring DA, Tomic D, Wuerfel J, Radue EW, Kappos L, Sprenger T
doi: 10.1007/s10548-018-0652-9.
Multiple Sclerosis
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
Mult Scler.
Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL
doi: 10.1177/1352458518814117.
Multiple Sclerosis
Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries
Mult Scler.
Kalkers NF, Galan I, Kerbrat A, Tacchino A, Kamm CP, O'Connell K, McGuigan C, Edan G, Montalban X, Uitdehaag BM, Mokkink LB
doi: 10.1177/1352458519895450.
Multiple Sclerosis
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
Eur J Neurol.
Havrdova E, Giovannoni G, Gold R, Fox RJ, Kappos L, Phillips JT, Okwuokenye M, Marantz JL
doi: 10.1111/ene.13272.
Aging and Cognitive FunctionsMultiple Sclerosis
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
J Neurol.
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group
doi: 10.1007/s00415-017-8642-5.
Multiple Sclerosis
Longitudinal analysis of white matter and cortical lesions in multiple sclerosis
Neuroimage Clin.
Fartaria MJ, Kober T, Granziera C, Bach Cuadra M
doi: 10.1016/j.nicl.2019.101938.